Cerebral CEO and co-founder Kyle Robertson is leaving his role at the digital mental health company amid growing controversy over its prescription practices, particularly for controlled substances like Adderall.
Dr. David Mou, who served as President and Chief Medical Officer of Cerebral, will assume the reins as CEO effective immediately. He added the chairmanship earlier this month. In addition to the CEO shakeup, COO Jessica Muse will now take over as president and Thomas Insel, former director of the National Institute of Mental Health and a clinical advisor to the company, will join Cerebral’s board of directors.
The Wall Street Journal Y Bloomberg reported that the board agreed last night to replace Robertson. According to him WSJRobertson did not participate in the meeting and lost access to Cerebral’s Slack messaging system without notice.
BECAUSE IT IS IMPORTANT
In recent months, Cerebral has faced increasing scrutiny over its controlled substance prescription practices. In late April, a former executive sued the company, claiming he was fired after raising concerns about patient safety. He said that Cerebral aimed to prescribe medication to all of its ADHD patients to increase retention. In a statement, the mental health company said he believed those allegations were “meritless.”
Earlier this month, the company confirmed that he had received a grand jury subpoena from the United States Attorney’s Office for the Eastern District of New York as part of an investigation into possible violations of the Controlled Substances Act.
Around the same time, Cerebral said that pause the prescription of controlled substances to new patients. This week, the digital mental health company confirmed that it would stop prescribing most controlled substances to new and existing patients, though it would continue to offer medication for the treatment of opioid use disorder.
IN THE REGISTRY
“We thank Kyle for his service. His vision resulted in what Cerebral is today: a leading provider of urgently needed mental health services for people who were unable or unable to obtain treatment,” Mou said in a statement.
“The timing of his idea was fortuitous. When the pandemic hit, Cerebral became a lifeline for people in need of mental health services. Kyle led the company through the rapid growth that followed, helping hundreds of thousands of patients access effective and safe care.As Cerebral enters its next phase of growth, we look forward to expanding our services, guided as always by evidence-based clinical protocols, to help those struggling with mental health issues silent”.